Business Context and Reporting Period
This Form 8-K filing by IRIDEX Corporation (IRIX) is dated March 27, 2020, with the report signed on March 30, 2020. The filing discloses executive leadership changes within the company's finance department.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial figures disclosed relate to executive compensation arrangements:
- Retirement consulting fee for Romeo R. Dizon: Approximately $60,000.
- Hourly consulting rate for Interim CFO James Mackaness (via FLG Partners): $400 per hour.
Material Changes
The primary material change reported is the departure of Romeo R. Dizon as Vice President of Finance, effective March 27, 2020. The filing explicitly states that Mr. Dizon's retirement was not the result of any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Management Commentary
James Mackaness was appointed as Interim Chief Financial Officer on a part-time basis, effective March 27, 2020. Mr. Mackaness is a partner with FLG Partners, LLC, and has previously served as CFO for the Company (2008–2012) and other medical technology firms. The consulting agreement with FLG Partners is indefinite and terminable by either party with 30 days' written notice. No forward-looking guidance or risk factors specific to financial performance are included in this report.
Investor Verification Checklist
- Verify the duration and total cost of the interim CFO arrangement given the hourly rate structure.
- Confirm the timeline for appointing a permanent Chief Financial Officer to replace the interim arrangement.
- Review the attached Press Release (Exhibit 99.1) for additional context on the leadership transition.
- Check subsequent filings for any impact of the CFO transition on financial reporting timelines or internal controls.